ISSCD President awarded prestigious prize for excellence in celiac disease research

Digestive Disease Week, Chicago, USA took place 6-9 May 2023. At the event, Marilyn Geller, CEO of the Celiac Disease Foundation, USA presented the Foundation's $25,000 Prize for Excellence in Celiac Disease Research to Dr Bob Anderson, current President of the ISSCD.

Dr Anderson is a consultant gastroenterologist, EndosQ, Mackay, honorary senior fellow, Wesley Medical Research, Brisbane and director/CEO and co-founder of Novoviah Pharmaceuticals, Brisbane, Australia. Dr Anderson has a global and multi-disciplinary perspective on celiac disease.

Over the past 30 years he has developed a diverse set of skills and has had extended periods living in four countries while developing expertise in clinical, scientific, commercial and patient support aspects of celiac disease. He is an adult gastroenterologist, translational immunologist, and pharmaceutical and diagnostic developer. 

A very worthy recipient of such a prize - congratulations Dr Anderson!